Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.

<h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerativ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Claudio D'Addario, Andrea Di Francesco, Beatrice Arosio, Cristina Gussago, Bernardo Dell'Osso, Monica Bari, Daniela Galimberti, Elio Scarpini, A Carlo Altamura, Daniela Mari, Mauro Maccarrone
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:356f64993bd64394bf1b45b7d3c01d4d
record_format dspace
spelling oai:doaj.org-article:356f64993bd64394bf1b45b7d3c01d4d2021-11-18T07:15:41ZEpigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.1932-620310.1371/journal.pone.0039186https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22720070/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes.<h4>Methods</h4>We have studied the gene expression status and the epigenetic regulation of ECS components in peripheral blood mononuclear cells (PBMCs) of subjects with late-onset AD (LOAD) and age-matched controls (CT).<h4>Results</h4>We found an increase in fatty acid amide hydrolase (faah) gene expression in LOAD subjects (2.30 ± 0.48) when compared to CT (1.00 ± 0.14; *p<0.05) and no changes in the mRNA levels of any other gene of ECS elements. Consistently, we also observed in LOAD subjects an increase in FAAH protein levels (CT: 0.75 ± 0.04; LOAD: 1.11 ± 0.15; *p<0.05) and activity (pmol/min per mg protein CT: 103.80 ± 8.73; LOAD: 125.10 ± 4.00; *p<0.05), as well as a reduction in DNA methylation at faah gene promoter (CT: 55.90 ± 4.60%; LOAD: 41.20 ± 4.90%; *p<0.05).<h4>Conclusions</h4>Present findings suggest the involvement of FAAH in the pathogenesis of AD, highlighting the importance of epigenetic mechanisms in enzyme regulation; they also point to FAAH as a new potential biomarker for AD in easily accessible peripheral cells.Claudio D'AddarioAndrea Di FrancescoBeatrice ArosioCristina GussagoBernardo Dell'OssoMonica BariDaniela GalimbertiElio ScarpiniA Carlo AltamuraDaniela MariMauro MaccarronePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 6, p e39186 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Claudio D'Addario
Andrea Di Francesco
Beatrice Arosio
Cristina Gussago
Bernardo Dell'Osso
Monica Bari
Daniela Galimberti
Elio Scarpini
A Carlo Altamura
Daniela Mari
Mauro Maccarrone
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
description <h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes.<h4>Methods</h4>We have studied the gene expression status and the epigenetic regulation of ECS components in peripheral blood mononuclear cells (PBMCs) of subjects with late-onset AD (LOAD) and age-matched controls (CT).<h4>Results</h4>We found an increase in fatty acid amide hydrolase (faah) gene expression in LOAD subjects (2.30 ± 0.48) when compared to CT (1.00 ± 0.14; *p<0.05) and no changes in the mRNA levels of any other gene of ECS elements. Consistently, we also observed in LOAD subjects an increase in FAAH protein levels (CT: 0.75 ± 0.04; LOAD: 1.11 ± 0.15; *p<0.05) and activity (pmol/min per mg protein CT: 103.80 ± 8.73; LOAD: 125.10 ± 4.00; *p<0.05), as well as a reduction in DNA methylation at faah gene promoter (CT: 55.90 ± 4.60%; LOAD: 41.20 ± 4.90%; *p<0.05).<h4>Conclusions</h4>Present findings suggest the involvement of FAAH in the pathogenesis of AD, highlighting the importance of epigenetic mechanisms in enzyme regulation; they also point to FAAH as a new potential biomarker for AD in easily accessible peripheral cells.
format article
author Claudio D'Addario
Andrea Di Francesco
Beatrice Arosio
Cristina Gussago
Bernardo Dell'Osso
Monica Bari
Daniela Galimberti
Elio Scarpini
A Carlo Altamura
Daniela Mari
Mauro Maccarrone
author_facet Claudio D'Addario
Andrea Di Francesco
Beatrice Arosio
Cristina Gussago
Bernardo Dell'Osso
Monica Bari
Daniela Galimberti
Elio Scarpini
A Carlo Altamura
Daniela Mari
Mauro Maccarrone
author_sort Claudio D'Addario
title Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
title_short Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
title_full Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
title_fullStr Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
title_full_unstemmed Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
title_sort epigenetic regulation of fatty acid amide hydrolase in alzheimer disease.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d
work_keys_str_mv AT claudiodaddario epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT andreadifrancesco epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT beatricearosio epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT cristinagussago epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT bernardodellosso epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT monicabari epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT danielagalimberti epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT elioscarpini epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT acarloaltamura epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT danielamari epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
AT mauromaccarrone epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease
_version_ 1718423718036766720